mRNA and Delivery / Lipids and LNP Excipients
LP-01
Quick view. LP-01 (CAS 1799316-64-5) is listed for identity-scoped inquiry through OROGO. Current availability, exact chemical form, specification and packaging are confirmed for each request; this listing makes no stock or suitability claim. Catalog target purity: Specification by inquiry. Availability: Inquiry only — contact OROGO to confirm current availability.
Request a quote Review request checklist
Catalog status
Scope. "Available for inquiry" is not a stock claim. Operating tier is a catalog-merchandising priority. Development phase and program context are shown only where the reviewed catalog source provides a mapping; they describe the chemistry platform and do not claim that OROGO supplies the named program.
| Supply status | Available for inquiry |
|---|---|
| Operating tier | Priority |
| Reviewed supporting program count | 2 |
| Representative chemistry-platform program | NTLA-2001 |
| Highest development phase | Marketed |
| CAS status | Published registry number |
Product profile
LP-01 is classified as mrna and delivery / lipids and lnp excipients (Formula C50H93NO9; molecular weight 852.30).
LP-01 is supplied for research use within the Specialty Amphiphilic Compounds product family.
For LP-01, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- CCD Lipid01
Useful catalog search terms
- 1799316-64-5
- LP-01 / CCD Lipid01
Physicochemical data
| Reviewed identity | LP-01 / CCD Lipid01 |
|---|---|
| PubChem CID | 118178658 |
| InChI | InChI=1S/C50H93NO9/c1-6-11-14-17-20-21-22-23-24-25-26-27-28-29-32-36-47(52)58-43-46(45-60-50(54)57-42-35-39-51(9-4)10-5)44-59-48(53)37-38-49(55-40-33-30-18-15-12-7-2)56-41-34-31-19-16-13-8-3/h20-21,23-24,46,49H,6-19,22,25-45H2,1-5H3/b21-20-,24-23- |
| InChIKey | CHTXXFZHKGGQGX-IFLFXUNCSA-N |
| SMILES | CCCCCCCCOC(CCC(=O)OCC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COC(=O)OCCCN(CC)CC)OCCCCCCCC |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.